% | $
Quotes you view appear here for quick access.

Geron Corporation Message Board

  • sidesaddlex sidesaddlex Oct 6, 2013 11:36 AM Flag

    The 100 year pipeline (telomeres, stemcells)

    Geron is already part of history. Stemcells and telomeres are the future of medicine, and keys to enhancing the understanding of how cells grow, how they age and how that growth can be controlled. This is equally true for normal cells and malignant cells. Nobel prizes have already been awarded, and more are likely to come. No doubt Geron is too small to do much more, but new, deeper pockets are about to take up the quest. Geron, as a stock, should rise in the short term. The Mayo studies will be encouraging, and point in a positive direction.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • It is probably true that this is the "future of medicine". Some company will be a superstar. Will it be Geron? I think they have some good bets, but is it their time?

    • I think it's clear the Mayo studies will be encouraging, the question is how encouraging? How many cr's and how many pr's? Will they blow it out of the water or not? Will Scarlett's supressed excitment and squeals translate into something concrete or was he just having the vapors?

      Geron's future and my condition deep underwater -- not to mention the halt and the lame -- depends on the study. Go Geron, you little b......d.

2.625-0.015(-0.57%)9:34 AMEDT